We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Neurology

Neurology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Ischaemic Stroke Risk in Atrial Flutter Versus Atrial Fibrillation: Insights from a Finnish Nationwide Registry Study
CardiologyanticoagulationIschaemic Stroke

Ischaemic Stroke Risk in Atrial Flutter Versus Atrial Fibrillation: Insights from a Finnish Nationwide Registry Study

By MedXY|Sep 9, 2026

This Finnish nationwide study demonstrates that patients with atrial flutter have a substantially lower risk of ischaemic stroke compared to those with atrial fibrillation, highlighting important differences in thromboembolic risk profiles

Early Detection of Cerebral Small Vessel Disease: Diffusion MRI Reveals a Decade-Long Preclinical Phase Before White Matter Hyperintensities
Neurologycerebral small vessel diseasediffusion MRI

Early Detection of Cerebral Small Vessel Disease: Diffusion MRI Reveals a Decade-Long Preclinical Phase Before White Matter Hyperintensities

By MedXY|Sep 8, 2026

Diffusion MRI detects microstructural brain changes up to 16 years before white matter hyperintensities appear, offering a valuable early window for cerebral small vessel disease intervention and improved risk stratification.

Social Determinants of Health in Early to Mid-Adulthood and Risk of Early-Onset Stroke: A Comprehensive Review
Clinical Updateshealth disparitiesepidemiology

Social Determinants of Health in Early to Mid-Adulthood and Risk of Early-Onset Stroke: A Comprehensive Review

By MedXY|Sep 8, 2026

Accumulating evidence underscores how adverse social determinants of health (SDOH) from early adulthood heighten the risk of early-onset stroke, with dose-dependent effects and disparities by race and sex.

Gestational Changes in Antiseizure Medication Concentrations and the Impact of Polytherapy: Insights from a Prospective Multicenter Cohort Study in China
Clinical Updatespolytherapylamotrigine

Gestational Changes in Antiseizure Medication Concentrations and the Impact of Polytherapy: Insights from a Prospective Multicenter Cohort Study in China

By MedXY|Sep 8, 2026

Pregnancy significantly reduces antiseizure medication concentrations, with lamotrigine showing the greatest decline. Polytherapy and body weight modulate these changes, underscoring the importance of individualized therapeutic drug monitor

Immigration Status and Acute Stroke ICU Care: Insights from Ontario’s Population-Based Study
Critical Carehealth disparitiesICU care

Immigration Status and Acute Stroke ICU Care: Insights from Ontario’s Population-Based Study

By MedXY|Sep 8, 2026

This retrospective cohort study explores how immigration status influences ICU admission rates and length of stay among ischemic stroke patients in Ontario, revealing longer ICU stays for immigrants despite similar admission rates compared

Ticagrelor-Aspirin Dual Therapy After Thrombolysis in Moderate Ischemic Stroke: Insights from Infarct Patterns in the TAPIS Trial
CardiologyDiffusion-weighted imagingThrombolysis

Ticagrelor-Aspirin Dual Therapy After Thrombolysis in Moderate Ischemic Stroke: Insights from Infarct Patterns in the TAPIS Trial

By MedXY|Sep 6, 2026

TAPIS subgroup analysis reveals that ticagrelor-aspirin combined with thrombolysis may improve outcomes in moderate ischemic stroke patients with multiple acute infarcts, without increasing hemorrhage risk, suggesting infarct pattern as a p

Cilostazol Therapy in Intracerebral Hemorrhage: Enhancing Dural Lymphatic Function for Neuroprotection
Clinical Updatesneuroprotectioncilostazol

Cilostazol Therapy in Intracerebral Hemorrhage: Enhancing Dural Lymphatic Function for Neuroprotection

By MedXY|Sep 6, 2026

Cilostazol promotes dural lymphatic remodeling and hematoma clearance post-ICH without increasing bleeding risk, representing a promising therapeutic strategy to improve neurological outcomes.

CSF Biomarkers as Indicators of Disease Severity in Probable Cerebral Amyloid Angiopathy: Insights Beyond MRI
NeurologyMRIβ-Amyloid

CSF Biomarkers as Indicators of Disease Severity in Probable Cerebral Amyloid Angiopathy: Insights Beyond MRI

By MedXY|Sep 6, 2026

This study demonstrates that cerebrospinal fluid beta-amyloid peptides correlate with MRI markers of disease severity in probable cerebral amyloid angiopathy, suggesting CSF biomarkers provide a direct measure of vascular amyloid burden, in

Unraveling Central Autonomic Network Disruptions Underlying Cardiorespiratory Dysfunction in Temporal Lobe Epilepsy
Cardiologytemporal lobe epilepsyCardiorespiratory Regulation

Unraveling Central Autonomic Network Disruptions Underlying Cardiorespiratory Dysfunction in Temporal Lobe Epilepsy

By MedXY|Sep 6, 2026

This study reveals that central autonomic network alterations in temporal lobe epilepsy patients contribute to interictal cardiorespiratory dysfunction, potentially increasing SUDEP risk, and highlights connectivity changes post-surgery imp

Prednisone Use Post-Acoustic Neuroma Surgery Does Not Prevent Delayed Facial Nerve Palsy: A Retrospective Analysis
Neurologyprednisonecorticosteroids

Prednisone Use Post-Acoustic Neuroma Surgery Does Not Prevent Delayed Facial Nerve Palsy: A Retrospective Analysis

By MedXY|Sep 5, 2026

A retrospective study found that postoperative prednisone tapering does not reduce delayed facial nerve palsy incidence following acoustic neuroma resection and carries a 10% risk of steroid-related side effects.

Assessing Age-Related Bias in EQ-5D-5L Quality of Life Measures Among Acute Ischemic Stroke Patients: Insights from the ACT Trial
NeurologyEQ-5D-5LDifferential Item Functioning

Assessing Age-Related Bias in EQ-5D-5L Quality of Life Measures Among Acute Ischemic Stroke Patients: Insights from the ACT Trial

By MedXY|Sep 5, 2026

This study evaluates differential item functioning in the EQ-5D-5L questionnaire among acute ischemic stroke patients, revealing minimal impact of age-related biases on quality of life measurement across sex and treatment groups.

BCKDK: Unlocking a New Hypoxia-Sensitive Target to Mitigate Cerebral Ischemic Injury
Neurologyhypoxiabranched-chain amino acids

BCKDK: Unlocking a New Hypoxia-Sensitive Target to Mitigate Cerebral Ischemic Injury

By MedXY|Sep 5, 2026

This article details how BCKDK, a hypoxia-induced kinase, disrupts branched-chain amino acid metabolism to worsen neuronal injury in cerebral ischemia, highlighting its potential as a novel therapeutic target.

Unraveling the Link Between Alzheimer’s Pathology, Sleep Disturbances, and Cognitive Decline in Late-Onset Unexplained Epilepsy
NeurologycognitionAlzheimer pathology

Unraveling the Link Between Alzheimer’s Pathology, Sleep Disturbances, and Cognitive Decline in Late-Onset Unexplained Epilepsy

By MedXY|Sep 5, 2026

Elevated plasma p-tau217 correlates with cognitive impairment and altered sleep microarchitecture in older adults with late-onset unexplained epilepsy, highlighting potential pathways linking neurodegeneration, epilepsy severity, and sleep

Unraveling Alzheimer’s Disease Progression in Down Syndrome via Blood Proteome Dynamics
Neurologyblood proteomelongitudinal biomarkers

Unraveling Alzheimer’s Disease Progression in Down Syndrome via Blood Proteome Dynamics

By MedXY|Sep 5, 2026

Longitudinal analysis of blood proteins reveals distinctive trajectories and associations with cognitive decline in adults with Down syndrome, shedding light on Alzheimer’s disease pathophysiology in this high-risk group.

Evaluating Tirofiban Plus Aspirin in Branch Atheromatous Disease Stroke: Insights from the STRATEGY Trial
NeurologystrokeBranch Atheromatous Disease

Evaluating Tirofiban Plus Aspirin in Branch Atheromatous Disease Stroke: Insights from the STRATEGY Trial

By MedXY|Sep 5, 2026

The STRATEGY trial assessed whether combining tirofiban with aspirin improves outcomes in branch atheromatous disease (BAD)-related stroke but found no significant benefit over aspirin alone in preventing neurological deterioration or recur

Safety and Efficacy of Guanabenz in Early-Childhood Onset Vanishing White Matter: Insights from a Phase 1/2 Single-Arm Trial
Clinical Updatesvanishing white matterpediatric neurodegeneration

Safety and Efficacy of Guanabenz in Early-Childhood Onset Vanishing White Matter: Insights from a Phase 1/2 Single-Arm Trial

By MedXY|Sep 5, 2026

This review synthesizes recent evidence demonstrating guanabenz’s manageable safety profile and efficacy in delaying ambulatory decline in early-onset vanishing white matter disease, highlighting translational pharmacokinetic data and

Antiseizure Medication Use During Pregnancy: Implications for Fetal Growth from the EURAP Registry
NeurologyTăng trưởng thai nhiPregnancy

Antiseizure Medication Use During Pregnancy: Implications for Fetal Growth from the EURAP Registry

By MedXY|Sep 5, 2026

A comprehensive cohort study from the EURAP registry reveals that antiseizure medication, especially polytherapy and certain monotherapies, increases the risk of poor fetal growth, underscoring the need for optimized treatment strategies du

Revolutionizing Stroke Diagnosis: Noninvasive Thrombus Imaging with [18F]GP1 PET/CT
Neurology[18F]GP1 PETStroke Etiology

Revolutionizing Stroke Diagnosis: Noninvasive Thrombus Imaging with [18F]GP1 PET/CT

By MedXY|Sep 5, 2026

A novel noninvasive imaging technique using [18F]GP1 PET/CT enables direct identification of thrombi in acute ischemic stroke, improving etiologic classification and predicting recurrence risk, heralding mechanism-based stroke management.

Prenatal Organophosphate Exposure and Autism Traits: A Large-Scale Cohort Study Finds No Association
Neurologyorganophosphatechild neurodevelopment

Prenatal Organophosphate Exposure and Autism Traits: A Large-Scale Cohort Study Finds No Association

By MedXY|Sep 4, 2026

This large prospective cohort study found no significant association between prenatal organophosphate pesticide exposure and autism-related traits in children, after comprehensive adjustments including maternal diet and sociodemographic fac

Cherry Angiomas as a Novel Vascular Manifestation in Neurofibromatosis Type 1: Epidemiology and Mechanistic Insights
DermatologyCherry Angiomasneurofibromatosis type 1

Cherry Angiomas as a Novel Vascular Manifestation in Neurofibromatosis Type 1: Epidemiology and Mechanistic Insights

By MedXY|Sep 3, 2026

Cherry angiomas are significantly more prevalent and occur at younger ages in individuals with Neurofibromatosis Type 1 (NF1), linked to biallelic NF1 inactivation in vascular cells. This discovery expands the vascular phenotype of NF1 and

Prev
3 / 25
12345…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure

Browse by specialty

Open language-specific specialty feeds and department pages.

news6829 articlesCardiology1403 articlesClinical Updates1315 articlesOncology1176 articlesDiabetes & Endocrinology868 articlesNeurology834 articlesPublic Health605 articlesGastroenterology586 articles
Hematology-Oncology
513 articles
Pediatrics493 articles
Internal Medicine464 articles